Skip to main content

Advertisement

SpringerLink
Log in

Development of analytical methods for evaluating the quality of dissociated and associated amphiphilic poly(γ-glutamic acid) nanoparticles

  • Research Paper
  • Published:
Analytical and Bioanalytical Chemistry Aims and scope Submit manuscript

Abstract

A quantitative method of analyzing nanoparticles (NPs) for drug delivery is urgently required by researchers and industry. Therefore, we developed new quantitative analytical methods for biodegradable and amphiphilic NPs consisting of polymeric γ-PGA-Phe [phenylalanine attached to poly(γ-glutamic acid)] molecules. These γ-PGA-Phe NPs were completely dissociated into separate γ-PGA-Phe molecules by adding sodium dodecyl sulfate (SDS). The dissociated NPs were chromatographically separated to analyze parameters such as the γ-PGA-Phe content in the NPs, the impurities present [using reverse-phase (RP) HPLC with an ultraviolet (UV) detector], and the absolute MW [using size-exclusion chromatography (SEC) with refractive index detection (RI) and multiangle light scattering (MALS) detection, i.e., SEC-RI/MALS]. The chromatographic patterns of the NPs were equivalent to those of the component polymer (γ-PGA-Phe), and excellent chromatographic separation for the quantitative evaluation of NPs was achieved. To the best of our knowledge, this is the first report of the quantitative evaluation of NPs in the field of NP-based delivery systems. Furthermore, these methods were applied to optimize and evaluate the NP manufacturing process. The results showed that impurities were effectively removed from the γ-PGA-Phe during the manufacturing process, so the purity of the final γ-PGA-Phe NPs was enhanced. In addition, the appearance, clarity of solution, particle size, zeta potential, particle matter, osmolarity, and pH of the product were evaluated to ensure that the NPs were of the required quality. Our approach should prove useful for product and process characterization and quality control in the manufacture of NPs. γ-PGA-Phe NPs are known to be a powerful vaccine adjuvant, so they are expected to undergo clinical development into a practical drug-delivery system. The analytical methods established in this paper should facilitate the reliable and practical quality testing of NP products, thus aiding the clinical development of γ-PGA-Phe-based drug-delivery systems. Moreover, since these analytical methods employ commonly used reagents and chromatographic systems, the methods are expected to be applicable to other NP-based drug-delivery products too.

NPs were completely dissociated into separate γ-PGA-Phe polymeric molecules, which yielded a similar chromatogram to that seen for the NPs

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Wu L, Zhang J, Watanabe W. Physical and chemical stability of drug nanoparticles. Adv Drug Deliv Rev. 2011;63:456–69.

    Article  CAS  PubMed  Google Scholar 

  2. Du C, Zhao J, Fei J, Cui Y, Li J. Assembled microcapsules by doxorubicin and polysaccharide as high effective anticancer drug carriers. Adv Healthcare Mater. 2013;2:1246–51.

  3. Gao L, Cui Y, He Q, Yang Y, Fei J, Li J. Selective recognition of co-assembled thrombin aptamer and docetaxel on mesoporous silica nanoparticles against tumor cell proliferation. Chem Eur J. 2011;17:13170–4.

    Article  CAS  PubMed  Google Scholar 

  4. Yan X, Zhu P, Fei J, Li J. Self-assembly of peptide-inorganic hybrid spheres for adaptive encapsulation of guests. Adv Mater. 2010;22:1283–7.

    Article  CAS  PubMed  Google Scholar 

  5. Li D, Li C, Wang A, He Q, Li J. Hierarchical gold/copolymer nanostructures as hydrophobic nanotanks for drug encapsulation. J Mater Chem. 2010;20:7782–7.

    Article  CAS  Google Scholar 

  6. Thomas C, Rawat A, Weeks LH, Ahsan F. Aerosolized PLA and PLGA nanoparticles enhance humoral, mucosal and cytokine responses to hepatitis B vaccine. Mol Pharm. 2011;8:405–15.

    Article  CAS  PubMed  Google Scholar 

  7. Kim SY, Doh HJ, Jang MH, Ha YJ, Chung SI, Park HJ. Oral immunization with Helicobacter pylori-loaded poly(D,L-lactide-co-glycolide) nanoparticles. Helicobacter. 1999;4:33–9.

  8. Demento SL, Cui W, Criscione JM, Stern E, Tulipan J, Kaech SM. Role of sustained antigen release from nanoparticle vaccines in shaping the T cell memory phenotype. Biomaterials. 2012;33:4957–64.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Lü JM, Wang X, Muller CM, Wang H, Lin PH, Yao Q. Current advances in research and clinical applications of PLGA-based nanotechnology. Expert Rev Mol Diagn. 2009;4:325–41.

    Article  Google Scholar 

  10. McCall RL, Sirianni RW. PLGA nanoparticles formed by single- or double-emulsion with vitamin E-TPGS. J Vis Exp. 2013;(82):51015. https://doi.org/10.3791/51015.

  11. Cho EJ, Holback H, Liu KC, Abouelmagd SA, Park J, Yeo Y. Nanoparticle characterization: state of the art, challenges, and emerging technologies. Mol Pharm. 2013;10:2093–110.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Sokolova V, Knuschke T, Buer J, Westendorf AM, Epple M. Quantitative determination of the composition of multi-shell calcium phosphate-oligonucleotide nanoparticles and their application for the activation of dendritic cells. Acta Biomater. 2011;7:4029–36.

    Article  CAS  PubMed  Google Scholar 

  13. Akagi T, Baba M, Akashi M, Kunugi S. Polymers. In: Yamaoka T, editor. Nanomedicine. Berlin: Springer-Verlag; 2012. p. 31–64.

  14. Akagi T, Kaneko T, Kida T, Akashi M. Preparation of nanoparticles by the self-organization of polymers consisting of hydrophobic and hydrophilic segments: potential applications. J Control Release. 2005;108:226–36.

    Article  CAS  PubMed  Google Scholar 

  15. Uto T, Wang X, Sato K, Haraguchi M, Akagi T, Akashi M, et al. Targeting of antigen to dendritic cells with poly(gamma-glutamic acid) nanoparticles induces antigen-specific humoral and cellular immunity. J Immun. 2007;178:2979–86.

  16. Uto T, Akagi T, Hamasaki T, Akash M, Baba M. Uptake of biodegradable poly(γ-glutamic acid) nanoparticles and antigen presentation by dendritic cells in vivo. Immunol Lett. 2009;125:46–52.

    Article  CAS  PubMed  Google Scholar 

  17. Himeno A, Akagi T, Uto T, Wang X, Baba M, Ibuki K. Evaluation of the immune response and protective effects of vaccination in rhesus macaques with biodegradable nanoparticles carrying gp120 of human immunodeficiency virus. Vaccine. 2010;28:5377–85.

    Article  CAS  PubMed  Google Scholar 

  18. Okamoto S, Matsuura M, Akagi T, Akashi M, Tanimoto IT, Takahashi T, et al. Poly(γ-glutamic acid) nano-particles combined with mucosal influenza virus hemagglutinin vaccine protects against influenza virus infection in mice. Vaccine. 2009;27:5896–905.

  19. Akagi T, Wang X, Uto T, Baba M, Akashi M. Protein direct delivery to dendritic cells using nanoparticles based on amphiphilic poly(amino acid) derivatives. Biomaterials. 2007;28:3427–36.

    Article  CAS  PubMed  Google Scholar 

  20. Yamaguchi S, Tatsumi T, Takehara T, Sasakawa A, Yamamoto M, Kohga K, et al. EphA2-derived peptide vaccine with amphiphilic poly(γ-glutamic acid) nanoparticles elicits an anti-tumor effect against mouse liver tumor. Cancer Immunol Immunother. 2010;59:759–67.

  21. Sagadevan S, Podder J. Investigation of structural, SEM, TEM and dielectric properties of BaTiO3 nanoparticles. J Nano-Electron Phys. 2015;7:04008–1–-4.

  22. Lin WC, Yang MC. Novel silver/poly(vinyl alcohol) nanocomposites for surface-enhanced Raman scattering-active substrates. Macromol Rapid Commun. 2005;26:1942–7.

    Article  CAS  Google Scholar 

  23. Pyrz WD, Buttrey DJ. Particle size determination using TEM: a discussion of image acquisition and analysis for the novice microscopist. Langmuir. 2008;24:11350–60.

    Article  CAS  PubMed  Google Scholar 

  24. Ebenstein Y, Nahum E, Banin U. Tapping mode atomic force microscopy for nanoparticle sizing: tip−sample interaction effects. Nano Lett. 2002;2:945–50.

    Article  CAS  Google Scholar 

  25. Zhang B, Yan B. Analytical strategies for characterizing nanoparticle’s surface chemistry. Anal Bioanal Chem. 2010;396:973.

  26. Watson GD. Pharmaceutical analysis. 3rd ed. London: Churchill Livingstone; 2012.

    Google Scholar 

  27. Beckett AH, Stenlake JB. Practical pharmaceutical chemistry. 4th ed. New Delhi: CBS Publishers and Distributors Pvt. Ltd.; 1997.

  28. Higuchi T, Hansen B. Pharmaceutical analysis. 3rd ed. New Delhi: CBS Publishers and Distributors; 1997.

    Google Scholar 

  29. Ikeda M, Akagi T, Yasuoka T, Nagao M, Akashi M. Characterization and analytical development for amphiphilic poly(γ-glutamic acid) as raw material of nanoparticle adjuvants. J Pharma Biomed Anal. 2018;150:460–8.

    Article  CAS  Google Scholar 

  30. Schwartz M, Krull IS. Analytical regulatory and validation compliance. New York, USA: Marcel Dekker; 1997.

    Google Scholar 

  31. Riley CM, Rosanske TW, editors. Development and validation of analytical methods. Oxford, UK: Pergamon; 1996.

    Google Scholar 

  32. Miller JM, Crowther JB, editors. Analytical chemistry in a GMP environment. New York, USA: Wiley; 2000.

    Google Scholar 

  33. Ermer J, Miller JH, editors. Method validation in pharmaceutical analysis. Weinheim, Germany: Wiley-VCH Verlag; 2005.

    Google Scholar 

  34. Cho EJ, Holback H, Liu KC, Abouelmagd SA, Park J, Yeo Y. Nanoparticle characterization: state of the art, challenges, and emerging technologies. Mol Pharm. 2013;10:2093–110.

  35. Kazakevich Y, Loburutto BR. Stationary phases. In: Kazakevich Y, Loburutto BR, editors. HPLC for pharmaceutical scientists. Hoboken, NJ, USA: Wiley and Sons, Inc.; 2007. p. 92–8.

  36. Matsusaki M, Hiwatari K, Higashi M, Kaneko T, Akashi M. Nanosphere induced gene expression in human dendritic cells. Chem Lett. 2004;33:398–9.

    Article  CAS  Google Scholar 

  37. Akagi T, Baba M, Akashi M. Preparation of nanoparticles by the self-organization of polymers consisting of hydrophobic and hydrophilic segments: potential applications. Polymer. 2007;48:6729–47.

    Article  CAS  Google Scholar 

  38. Kaneko T, Higashi M, Matsusaki M, Akagi T, Akashi M. Self-assembled soft nanofibrils of amphipathic polypeptides and their morphological transformation. Chem Mater. 2005;17:2484–6.

  39. Jimenez VL, Leopold MC, Mazzitelli C. HPLC of monolayer-protected gold nanoclusters. Anal Chem. 2003;75:199–206.

    Article  CAS  PubMed  Google Scholar 

  40. Wilcoxon JP, Martin JE, Provencio P. Size distributions of gold nanoclusters studied by liquid chromatography. Langmuir. 2000;16:9912–20.

    Article  CAS  Google Scholar 

  41. Kim H, Akagi T, Akashi M. Preparation of size tunable amphiphilic poly(amino acid) nanoparticles. Macromol Biosci. 2009;9:842–8.

    Article  CAS  PubMed  Google Scholar 

  42. Yan H, Hou YF, Niu PF, Zhang K, Shoji T, Tsuboi Y, et al. Biodegradable PLGA nanoparticles loaded with hydrophobic drugs: confocal Raman microspectroscopic characterization. J Mater Chem B. 2015;3:3677–80.

  43. Kim H, Uto T, Akagi T, Baba M, Akashi M. Amphiphilic poly(amino acid) nanoparticles induce size-dependent dendritic cell maturation. Adv Funct Mater. 2010;20:3925–31.

    Article  CAS  Google Scholar 

  44. Akagi T, Higashi M, Kaneko T, Kida T, Akashi M. In vitro enzymatic degradation of nanoparticles prepared from hydrophobically-modified poly(gamma-glutamic acid). Macromol Biosci. 2005;5:598–602.

    Article  CAS  PubMed  Google Scholar 

  45. Ghanbarzadeh S, Valizadeh H, Milani PZ. The effects of lyophilization on the physico-chemical stability of sirolimus liposomes. Adv Pharm Bull. 2013;3:25–9.

    PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

We would like to thank Dr. Tetsuo Miwa, Dr. Masami Kusaka, Mr. Tatsuya Yasuoka, Mr. Jun Hirose, Mr. Hikaru Taira (Takeda Pharmaceutical Company, Ltd.), Prof. Masanori Baba (Kagoshima University), and Dr. Tomofumi Uto (University of Miyazaki) for their many suggestions and support.

Author information

Authors and Affiliations

  1. Pharmaceutical Sciences, Takeda Pharmaceutical Company Limited, 2-17-85 Jusohonmachi, Yodogawa-ku, Osaka, 532-8686, Japan

    Mayumi Ikeda & Masao Nagao

  2. Building Block Science Joint Research Chair, Graduate School of Frontier Biosciences, Osaka University, 1-3 Yamadaoka, Suita, 565-0871, Japan

    Mayumi Ikeda, Takami Akagi & Mitsuru Akashi

Authors
  1. Mayumi Ikeda
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Takami Akagi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Masao Nagao
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Mitsuru Akashi
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Mitsuru Akashi.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ikeda, M., Akagi, T., Nagao, M. et al. Development of analytical methods for evaluating the quality of dissociated and associated amphiphilic poly(γ-glutamic acid) nanoparticles. Anal Bioanal Chem 410, 4445–4457 (2018). https://doi.org/10.1007/s00216-018-1099-2

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00216-018-1099-2

Keywords

Search

Navigation